Clinical Trial Detail

NCT ID NCT01325441
Title A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

Advanced Solid Tumor

ovarian cancer

peritoneum cancer

breast cancer

fallopian tube cancer

esophageal cancer

gastroesophageal junction adenocarcinoma

melanoma

lung non-small cell carcinoma

stomach cancer

Therapies

Napabucasin + Paclitaxel

Age Groups: adult

No variant requirements are available.